Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

IM Cannabis (IMCC) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to 27.9%.

  • IM Cannabis' EBITDA Margin rose 388200.0% to 27.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.66%, marking a year-over-year increase of 659800.0%. This contributed to the annual value of 0.01% for FY2024, which is 222200.0% up from last year.
  • IM Cannabis' EBITDA Margin amounted to 27.9% in Q3 2025, which was up 388200.0% from 11.57% recorded in Q2 2025.
  • Over the past 5 years, IM Cannabis' EBITDA Margin peaked at 155.73% during Q2 2022, and registered a low of 899.17% during Q3 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 0.0% (2025), whereas its average is 53.63%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first crashed by -8402200bps in 2022, then soared by 8834900bps in 2023.
  • Over the past 5 years, IM Cannabis' EBITDA Margin (Quarter) stood at 0.09% in 2021, then tumbled by -249346bps to 234.41% in 2022, then surged by 30bps to 163.8% in 2023, then surged by 143bps to 70.68% in 2024, then crashed by -61bps to 27.9% in 2025.
  • Its last three reported values are 27.9% in Q3 2025, 11.57% for Q2 2025, and 0.0% during Q1 2025.